UK markets closed

Pfizer Inc. (0Q1N.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
50.83+0.25 (+0.49%)
At close: 07:12PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3N/A
S&P500 52-week change 3-16.45%
52-week high 350.82
52-week low 350.26
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 85.61B
% held by insiders 10.05%
% held by institutions 170.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.58
Trailing annual dividend yield 33.12%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)03 Jul 2022

Profitability

Profit margin 28.94%
Operating margin (ttm)38.05%

Management effectiveness

Return on assets (ttm)13.19%
Return on equity (ttm)37.40%

Income statement

Revenue (ttm)101.28B
Revenue per share (ttm)18.06
Quarterly revenue growth (yoy)46.80%
Gross profit (ttm)50.63B
EBITDA 43.52B
Net income avi to common (ttm)29.48B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)78.10%

Balance sheet

Total cash (mrq)33.31B
Total cash per share (mrq)5.93
Total debt (mrq)40.49B
Total debt/equity (mrq)46.29
Current ratio (mrq)1.42
Book value per share (mrq)15.59

Cash flow statement

Operating cash flow (ttm)31.45B
Levered free cash flow (ttm)29.06B